How Long Does a Contraceptive Implant Last?

The etonogestrel contraceptive implant, sold as Nexplanon (and previously as Implanon), is approved for three years of use. That is the official, FDA-labeled duration. But a growing body of research suggests the device continues to prevent pregnancy for at least five years, and many clinicians now offer extended use beyond the three-year mark. Whether you should plan around three years or five depends on your individual situation, your provider’s comfort with the evidence, and a few factors that can shorten the implant’s effective window.

What the Implant Does and How Long It Is Approved For

The contraceptive implant is a single flexible rod, about the size of a matchstick, inserted just under the skin of the inner upper arm. It releases a steady low dose of etonogestrel, a synthetic progestin, which prevents pregnancy primarily by stopping ovulation. The hormone also thickens cervical mucus, making it harder for sperm to reach an egg. The current version, Nexplanon, carries regulatory approval for three years of continuous use, at which point your provider is supposed to remove or replace it.

Older implant systems used different hormones or configurations. Norplant, which is no longer available in many countries, consisted of six small capsules and was approved for five years. Jadelle, a two-rod levonorgestrel system still used in some regions, is also approved for five years. But the single-rod etonogestrel implant is by far the most widely used version today, and its three-year label is the one most people encounter.

The Evidence for Using It Beyond Three Years

The three-year label does not mean the implant stops working on day 1,096. The hormone level drops gradually over time, and researchers have been studying whether the remaining etonogestrel is still enough to prevent pregnancy in years four and five. The results so far are reassuring. A systematic review found emerging evidence that extending the etonogestrel implant beyond its approved three years is feasible.¹

One of the most cited studies followed over 200 women who kept their etonogestrel implant in place for at least five years. No pregnancies occurred during the additional two years of follow-up beyond the labeled duration, and the overall five-year pregnancy rate was roughly 0.6 per 100 woman-years.² A separate study tracked implant users for two years past the FDA-approved expiration and documented zero pregnancies among 291 women contributing over 440 woman-years of follow-up. The calculated failure rate in both the fourth and fifth years was zero.³

These numbers are striking, but they come with a caveat worth understanding. The studies are not enormous randomized trials, and confidence intervals at five years are wider than at three. The evidence strongly suggests the implant remains highly effective for five years, but it has not yet been enough for regulators to officially extend the label. Some professional guidelines, however, have already incorporated the data, and many providers will discuss extended use with you if you are interested.

Why Most Clinics Still Say Three Years

If the research looks this good, you might wonder why your clinic insists on replacing the implant right at three years. A national mystery-shopper study called clinics across the United States to ask about extended use and found that roughly two-thirds either recommended replacement at three years or could not provide information about using the implant longer.⁴ Only about a third of clinics offered extended use as an option. The gap between research findings and clinical practice is real, and it is mostly driven by the fact that the FDA label still says three years. Many providers are cautious about recommending off-label use, and insurance coverage for a replacement visit is straightforward at three years but may get complicated if you want to delay.

A qualitative study exploring why patients decide to replace or extend their implant found that decisions were shaped by trust in clinical guidance, personal symptom experiences, and a desire for more information. Some patients replaced their implant early due to side-effect concerns, while those who chose extended use often did so to avoid the discomfort of a removal-and-reinsertion procedure, especially when they trusted their clinician’s advice that the device was still working.⁵

Factors That Can Shorten the Effective Window

Even within the approved three-year period, certain medications can undermine the implant’s protection by lowering etonogestrel levels in your blood. The mechanism involves liver enzymes that speed up the breakdown of the hormone. The best-documented culprits are enzyme-inducing drugs, especially some medications for epilepsy and HIV.

Carbamazepine, a widely used anti-seizure drug, is one of the clearest examples. In a study of ten implant users who started carbamazepine, the median etonogestrel level dropped from about 158 pg/mL to around 51 pg/mL. In eight of those ten women, etonogestrel fell below 90 pg/mL, the threshold researchers use as a marker for reliable ovulation suppression.⁶ That threshold comes from pharmacokinetic work establishing that concentrations below 90 pg/mL leave enough hormonal room for an egg to mature and be released.⁷

Certain antiretroviral drugs used to treat HIV can also interfere. A case series documented unintended pregnancies in implant users taking efavirenz-based regimens, prompting a warning that the implant should be used cautiously in that population.⁸ More broadly, a case report on antiepileptic medications noted that while the interaction itself is not physically harmful, it reduces the implant’s ability to do its job.⁹

If you take any of these medications, your provider will typically recommend a backup or alternative contraceptive method rather than relying on the implant alone. This is one of the few situations where the implant’s reliability genuinely drops during its approved lifespan.

Does Body Weight Affect How Long It Works?

This is a common worry, and the short answer is that the implant remains highly effective across a wide range of body weights during its approved three-year period. A study tracking nearly 1,400 woman-years of implant use found just one unintended pregnancy, which occurred in a participant with a BMI above 30. The failure rate among participants with a healthy weight and among those classified as overweight was zero, while the rate among participants classified as obese was 0.23 per 100 woman-years. The study found no statistically significant difference in failure rates between the implant and IUDs at any weight category.¹⁰

Where body weight might matter more is in the extended-use window. Because etonogestrel levels decline over time, and higher body mass can dilute circulating hormone concentrations, heavier individuals may reach the threshold for reduced protection sooner. The extended-use studies have not specifically broken out results by BMI with enough statistical power to give definitive guidance, so if you are considering keeping your implant past three years and have a higher BMI, that is worth a conversation with your provider.

Bleeding Changes and Why People Remove It Early

The implant’s lifespan on paper and how long people actually keep it are two different things. A substantial number of users request removal before the three years are up, and the primary reason is changes in bleeding patterns. Studies in multiple settings have consistently found that irregular or prolonged bleeding is the most commonly cited reason for early removal, followed by weight gain, headaches, and decreased libido.¹¹¹²

One thing that often gets lost in pre-insertion counseling is that the bleeding pattern tends to improve over time. In a large randomized trial, the median number of bleeding and spotting days per 90-day period dropped from about 33-34 days early on to around 19-21 days by the final year. Prolonged bleeding episodes fell dramatically too, from about two-thirds of users in the first period to roughly a quarter by the end of the study.¹³ A separate long-term study in China found a similar trajectory, with prolonged bleeding dropping from about 69% of users early on to 26% by the end of the study period.¹⁴

An Ethiopian study found that about 23% of implant users requested removal before 2.5 years, with side effects being the leading reason. But the study also highlighted a telling pattern: women who had not been counseled about possible side effects before insertion, and those who were not told they could return to the clinic if problems arose, were significantly more likely to discontinue early.¹⁵ This suggests that good upfront counseling about what to expect in the first few months can make the difference between someone sticking with the implant long enough for the bleeding to settle down and someone requesting removal during the roughest phase.

How Quickly Fertility Returns After Removal

If you are keeping the implant in with a future pregnancy in mind, the good news is that fertility comes back fast. Unlike some hormonal methods that can delay ovulation for months, the implant’s effects wear off within weeks. Among former etonogestrel implant users, over 90% showed evidence of ovulation within three weeks in one study, and in another, 86% of former users had their period return within three months.¹⁶ For the older levonorgestrel implant, the first ovulation was detected as early as three days after removal in one study participant, with the latest at 47 days. The speed of return is one of the implant’s genuine advantages over some other long-acting methods.

What Removal Actually Involves

Removal is typically a quick office procedure. Your provider numbs the area, makes a small incision, and slides the rod out. For the vast majority of people, the whole thing takes a few minutes. But in a small number of cases, removal can be tricky. The most common complication is the implant becoming encased in fibrous scar tissue, which makes it harder to grip and pull out. A large observational study of over 5,100 removal procedures found that all but one were successful, and the single failure involved an implant lodged in deep muscle tissue. No implants had migrated outside the arm.¹⁷

When an implant cannot be felt under the skin, imaging comes into play. Ultrasound is the first-line tool, and X-ray can also help since the newer Nexplanon device contains barium to make it visible on imaging. For deeply placed or migrated implants that still cannot be located, MRI can be useful.¹⁸ In rare complicated cases involving implants adherent to nerves or embedded in muscle, a multidisciplinary surgical approach has been described, sometimes involving a peripheral nerve specialist.¹⁹ The design of Nexplanon’s insertion applicator was specifically updated to reduce the risk of deep placement, which was a known contributor to difficult removals with the earlier Implanon device.²⁰

The Polymer Holding It All Together

The implant rod itself is made from ethylene vinyl acetate (EVA), a medical-grade copolymer that acts as a reservoir for the hormone. One question people sometimes have is whether the material degrades over time, potentially releasing harmful byproducts. Toxicological studies on EVA have found that it produces no adverse local or systemic response over extended periods inside the body, and the overall safety profile of the polymer has been characterized as excellent.²¹ The rod does not dissolve or break down. When it is removed after three, four, or five years, it comes out structurally intact. This means there is no concern about leaving behind fragments, and it also means the question of “how long does it last” is purely about hormone output, not about the physical device falling apart.

Comparing Longevity With Other Long-Acting Methods

If lifespan is a major consideration in choosing a method, it helps to know where the implant sits relative to its closest competitors. Hormonal IUDs, depending on the brand and dose, are approved for anywhere from three to eight years, with the highest-dose levonorgestrel IUD (52 mg) now labeled for up to eight years in some markets. The copper IUD is approved for ten years or more. The implant’s three-year label is the shortest among these options on paper, though its likely effective duration of five years closes that gap.

The extended-use study that tracked both implant and IUD users past their labeled durations found that the implant had zero pregnancies through year five, while the levonorgestrel IUD had a small but nonzero failure rate in years six and seven.³ This does not mean the implant is “better” than the IUD. The methods differ in placement, side-effect profiles, and who is a good candidate for each. But it does illustrate that the implant punches above its labeled weight class when it comes to duration of protection.